PhaseBio Pharmaceuticals Inc: key financial figures for fiscal year 2021 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2021)
- $10.8M
- Net Income/Loss (FY2021)
- -$131.1M
- Total Assets (FY2021)
- $60.5M
- Total Equity (FY2021)
- -$93.0M
- Cash Flows from Operating Activities (FY2021)
- -$47.4M
Source: PhaseBio Pharmaceuticals Inc 10-K filing (FY2021). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
